BioSpace News Archive

In today’s Senior Living and Health Care environments, prevention and care of residents and patients is a priority. Access to telehealth and telemedicine via ubiquitous and reliable network and Internet connectivity is an absolute must-have and no longer an “opti

PMI Biopharma Solutions a provider of research, pharmaceutical development, and early-phase clinical manufacturing services and Nashville Biosciences, a clinical-genomic and bioinformatics company, today announced a strategic collaboration to leverage both parties’ unique strengths to provide their customers with an integrated product offering around drug discovery and development.

CVS Health (NYSE: CVS) today announced several steps to support Aetna members in response to the COVID-19 outbreak.

Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, received FDA approval for their generic version of Thiotepa 15mg and 100mg vials for injection.

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, continues to receive inquiries regarding the potential of Brilacidin, the Company’s novel defensin mimetic compound, to treat COVID-19, more generically called “coronavirus,” given the urgent worldwide need to discover treatments and vaccines for the deadly epidemic.

Spherix Incorporated (Nasdaq: SPEX) today announced it has executed an exclusive option agreement (“Option”) with the University of Maryland, Baltimore (UMB) for the technology set forth in Patent number 10,434,116 “Methods of Treating Coronavirus Infection.

RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Dear Shareholders: Since a recent teleconference call was held with shareholders there have been many things that have taken place

Starting today, SiriusXM channel 121 becomes “Coronavirus: What You Need To Know,” and will be available on both active and inactive SiriusXM radios, and on SiriusXM streaming platforms

The Anthem Blue Cross and Blue Shield Foundation, with $54 million in active grants nationally, is inviting nonprofit organizations in Ohio to submit funding proposals that address the state’s top health challenges.

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an agreement with Brigham and Women’s Hospital for an investigator-initiated study led by Richard D. Urman MD, MBA,